Article Text

Download PDFPDF
  1. Omar AlMasri1,
  2. Tom Massey1,
  3. Diptarup Mukhopadhyay2,
  4. R Jon Walters1
  1. 1Morriston Hospital
  2. 2Princess of Wales Hospital


Mitochondrial encephalomyelitis, lactic acidosis and stroke-like episodes (MELAS) syndrome is the most common of the rare mitochondrial disorders. It frequently is secondary to a point mutation in mitochondrial DNA m.3243 A to G. The main features of the disease include myopathy, encephalopathy, lactic acidosis, stroke-like episodes, seizures and migraine however the clinical presentations can vary widely. Age of onset of the disease has a wide range but patients are typically under 40 years of age, nonetheless cases have been reported in the elderly population. A number of drugs have been used for the management of patients with MELAS including CoEnzyme Q10, Vitamin K-3, Vitamin K-1, Ascorbate and Riboflavin. It is also important to note that seizures in MELAS can be difficult to manage often requiring a combination of antiepileptic drugs. We report the case of a 76-year-old man (the second oldest diagnosed case to the authors' knowledge) whose case exemplifies the complexity of diagnosing and managing these patients including the complications of the disease.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.